| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF-425-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB625-SP | |||
| Carrier Free | MAB625-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB430-SP | |||
| Carrier Free | MAB430-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF225-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 425-R1-050/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 636-R1-025/CF | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 350 | FAB425U-100UG | |||
| Alexa Fluor 405 | FAB425V-100UG | |||
| Alexa Fluor 488 | FAB425G-100UG | |||
| Alexa Fluor 532 | FAB425X-100UG | |||
| Alexa Fluor 594 | FAB425T-100UG | |||
| Alexa Fluor 647 | FAB425R-100UG | |||
| Alexa Fluor 700 | FAB425N-100UG | |||
| Alexa Fluor 750 | FAB425S-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB425-SP | |||
![N/A TNF RI/TNFRSF1A [HRP]](http://images.novusbio.com/fullsize2/DATA_TNF_RI_DRT100_ELISA_815.jpg "N/A TNF RI/TNFRSF1A [HRP]")
![N/A TNF RI/TNFRSF1A [HRP]](http://images.novusbio.com/fullsize2/DATA_TNF_RI_DRT100_ELISA_816.jpg)
![N/A TNF RI/TNFRSF1A [HRP]](http://images.novusbio.com/fullsize2/TNF_RI_DRT100_ELISA_175.jpg)
![Representative immunohistochemical staining for TNFR1 and TNFR2 in the kidneys.(A) Images were captured at 200× (a, b, c, d, i, j, k, l) and 100× (e, f, g, h, m, n, o, p) magnification. Images show the negative controls in the glomeruli (a, i) and tubulointerstitium (e, m) and TNFR1 and TNFR2 immunostaining in the glomeruli (b, j) and tubulointerstitium (f, n) of the normal kidneys, respectively. TNFR1 and TNFR2 immunostaining is shown in the glomeruli (c, k) and tubulointerstitium (g, o) of the kidneys from selected IgAN patients who had levels of serum TNFR2 that ranked in the lowest 10 [low group (LG)]. TNFR1 and TNFR2 immunostaining in the glomeruli (d, l) and tubulointerstitium (h, p) of the kidneys from selected IgAN patients who had levels of serum TNFR2 that ranked in the highest 10 [high group (HG)], respectively, are also shown. (B) Percentage of the TNFR1 and TNFR2-positive area in the kidneys were evaluated. Glomerular and tubulointerstitial TNFR expression was elevated significantly in IgAN patients compared with those in control (Ctrl) subjects. The tubulointerstitial TNFR2-positive area was significantly larger in HG than in LG. However, there was no significant difference in the tubulointerstitial TNFR1 and glomerular TNFR areas between LG and HG. * P < 0.01, **P < 0.001, †P < 0.0001. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0122212), licensed under a CC-BY license. Not internally tested by R&D Systems.](http://images.novusbio.com/fullsize/mab225_human-tnf-ri-tnfrsf1a-mab-clone-16803-41202410481119.jpg)
![N/A TNF RI/TNFRSF1A [Biotin]](http://images.novusbio.com/fullsize2/DATA_TNF_RI_DY225_ELISA_1795.jpg "N/A TNF RI/TNFRSF1A [Biotin]")
![N/A TNF RI/TNFRSF1A [HRP]](http://images.novusbio.com/fullsize2/DATA_TNF_RI_MRT10_ELISA_1028.jpg "N/A TNF RI/TNFRSF1A [HRP]")
![N/A TNF RI/TNFRSF1A [HRP]](http://images.novusbio.com/fullsize2/TNF_RI_MRT10_ELISA_318.jpg)
